| Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis S Paganoni, J Deng, M Jaffa, ME Cudkowicz, AM Wills Muscle & nerve 44 (1), 20-24, 2011 | 328 | 2011 |
| Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics H Ryberg, J An, S Darko, JL Lustgarten, M Jaffa, V Gopalakrishnan, ... Muscle & nerve 42 (1), 104-111, 2010 | 150 | 2010 |
| Uric acid levels predict survival in men with amyotrophic lateral sclerosis S Paganoni, M Zhang, A Quiroz Zárate, M Jaffa, H Yu, ME Cudkowicz, ... Journal of neurology 259, 1923-1928, 2012 | 128 | 2012 |
| SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapy L Winer, D Srinivasan, S Chun, D Lacomis, M Jaffa, A Fagan, ... JAMA neurology 70 (2), 201-207, 2013 | 122 | 2013 |
| Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics KA Lawton, MV Brown, D Alexander, Z Li, JE Wulff, R Lawson, M Jaffa, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15 (5-6), 362-370, 2014 | 97 | 2014 |
| Biochemical alterations associated with ALS KA Lawton, ME Cudkowicz, MV Brown, D Alexander, R Caffrey, JE Wulff, ... Amyotrophic Lateral Sclerosis 13 (1), 110-118, 2012 | 96 | 2012 |
| Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis M Van Blitterswijk, S Gulati, E Smoot, M Jaffa, N Maher, BT Hyman, ... Amyotrophic lateral sclerosis 12 (6), 430-438, 2011 | 43 | 2011 |
| Thermoregulation in brain injury R Gowda, M Jaffa, N Badjatia Handbook of clinical neurology 157, 789-797, 2018 | 23 | 2018 |
| Blood pressure management after endovascular therapy for acute ischemic stroke: the BEST-II randomized clinical trial EA Mistry, KW Hart, LT Davis, Y Gao, CJ Prestigiacomo, S Mittal, T Mehta, ... Jama 330 (9), 821-831, 2023 | 21 | 2023 |
| Association of refractory pain in the acute phase after subarachnoid hemorrhage with continued outpatient opioid use MN Jaffa, JE Podell, MC Smith, A Foroutan, A Kardon, WTW Chang, ... Neurology 96 (19), e2355-e2362, 2021 | 15 | 2021 |
| Admission features associated with paroxysmal sympathetic hyperactivity after traumatic brain injury: a case-control study JE Podell, SS Miller, MN Jaffa, M Pajoumand, M Armahizer, H Chen, ... Critical Care Medicine 49 (10), e989-e1000, 2021 | 14 | 2021 |
| Clinical trial testing lithium in ALS terminates early for futility SP Aggarwal, L Zinman, E Simpson, J McKinley, KE Jackson, H Pinto, ... Lancet neurology 9 (5), 481, 2010 | 14 | 2010 |
| Proposed BioRepository platform solution for the ALS research community A Sherman, R Bowser, D Grasso, B Power, C Milligan, M Jaffa, ... Amyotrophic Lateral Sclerosis 12 (1), 11-16, 2011 | 11 | 2011 |
| Pain trajectories following subarachnoid hemorrhage are associated with continued opioid use at outpatient follow-up MN Jaffa, RM Jha, J Elmer, A Kardon, JE Podell, BE Zusman, MC Smith, ... Neurocritical care 35 (3), 806-814, 2021 | 10 | 2021 |
| Neurologic outcomes after extracorporeal cardiopulmonary resuscitation: Recent experience at a single high-volume center JE Podell, EM Krause, R Rector, M Hassan, A Reddi, MN Jaffa, NA Morris, ... Asaio Journal 68 (2), 247-254, 2022 | 9 | 2022 |
| What does body mass index measure in amyotrophic lateral sclerosis and why should we care? S Paganoni, J Deng, M Jaffa, ME Cudkowicz, AM Wills Muscle & nerve 45 (4), 612, 2012 | 8 | 2012 |
| The NEALS primary lateral sclerosis registry S Paganoni, F De Marchi, J Chan, SK Thrower, NP Staff, N Datta, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21 (sup1), 74-81, 2020 | 6 | 2020 |
| Enhancing understanding and overcoming barriers in brain death determination using standardized education: a call to action MN Jaffa, MP Kirschen, M Tuppeny, AS Reynolds, K Lim-Hing, M Hargis, ... Neurocritical Care 39 (2), 294-303, 2023 | 5 | 2023 |
| A change of course: the case for a neurorecovery clinic MN Jaffa, JE Podell, M Motta Neurocritical Care 33, 610-612, 2020 | 5 | 2020 |
| Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. Amyotroph Lateral Scler Frontotemporal Degener. 2014; 15 (5–6 … KA Lawton, MV Brown, D Alexander, Z Li, JE Wulff, R Lawson, M Jaffa | 5 | 2014 |
